Atriance Trademark Details

Atriance was registered on Tuesday, December 21, 2004 and is currently owned by Glaxosmithkline LLC under the registration number 2913112 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 12 years ago on Friday, July 22, 2011, according to the United State Patent & Trademark Office
Word Mark Atriance
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Glaxosmithkline LLC of Wilmington, DE

View all trademarks for Glaxosmithkline LLC
Other Trademarks for Glaxosmithkline LLC

Previous Owners

Smithkline Beecham Corporation of Philadelphia, PA

View all trademarks for Smithkline Beecham Corporation
Other Trademarks for Smithkline Beecham Corporation

Glaxo Group Limited

View all trademarks for Glaxo Group Limited
Serial Number 78325270
Registration Number 2913112
Status Date Friday, July 22, 2011
Filing Date Friday, July 22, 2011
Registration Date Tuesday, December 21, 2004
Attorney Diane Fry Maginnis
Domestic Representative Diane Fry Maginnis

Correspondent

Diane Fry Maginnis
GlaxoSmithKline
LGTM, C.3157.3D
Five Moore Drive
Research Triangle Park NC 27709

Case File Statements

Goods & Services Pharmaceutical Preparations for the Treatment of Cancer

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, July 22, 2011
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.